ru24.pro
News in English
Июль
2024

Новости за 10.07.2024

Staff allowed to choose working hours in new trial - BBC

Top Stories (uk) - Google News (com) 

  1. Staff allowed to choose working hours in new trial  BBC
  2. Four-day week campaign to launch UK pilot looking at flexible working  The Guardian
  3. Was this council’s four-day week experiment really a success?  The Spectator
  4. Four-day week trial led to better public services, council claims  The Telegraph
  5. A four-day working week would help those who need it most – women  The Independent

Chinese, UAE Air Forces Conducting Joint Exercise in China's Xinjiang

Sputnik International 

MOSCOW (Sputnik) - The air forces of China and the United Arab Emirates (UAE) are carrying out a joint military exercise in China's Xinjiang Uygur Autonomous Region from late June through late July, the Chinese Defense Ministry said on Wednesday.

The 3 Most Undervalued Small-Cap Stocks to Buy in July 2024

InvestorPlace 

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Investors looking for big gains should consider these undervalued small-cap stocks. Each one is attractively valued and posting strong growth.

The post The 3 Most Undervalued Small-Cap Stocks to Buy in July 2024 appeared first on InvestorPlace.

More From InvestorPlace
  • The #1 AI Investment Might Be This Company You’ve Never Heard Of
  • Musk’s “Project Omega” May Be Set to Mint New Millionaires. Читать дальше...

Scientists pinpoint the reason women are more at risk of long Covid - as Ben Affleck's daughter Violet reveals - Daily Mail

Top Stories (us) - Google News (ru) 

  1. Scientists pinpoint the reason women are more at risk of long Covid - as Ben Affleck's daughter Violet reveals  Daily Mail
  2. Mini-Strokes, Gut Problems: Scientists See Links to an Old Bout of Covid  The Wall Street Journal
  3. The looming public health challenge of long covid  The Washington Post
  4. COVID's Hidden Toll: Full-Body Scans Reveal Long-Term Immune Effects  ScienceAlert
  5. Long COVID uncharacteristic immune cell activity and SARS-CoV-2 RNA found in the gut two... Читать дальше...

Violet Affleck hints at long Covid battle as study shows most at risk - Daily Mail

Google.com 

  1. Violet Affleck hints at long Covid battle as study shows most at risk  Daily Mail
  2. Mini-Strokes, Gut Problems: Scientists See Links to an Old Bout of Covid  The Wall Street Journal
  3. The looming public health challenge of long covid  The Washington Post
  4. COVID's Hidden Toll: Full-Body Scans Reveal Long-Term Immune Effects  ScienceAlert
  5. Long COVID uncharacteristic immune cell activity and SARS-CoV-2 RNA found in the gut two years after infection  Medical Xpress

Yearling Shire Colt - New

Dragon Driving 

POA
Big upstanding really well marked Shire yearling colt. Masses of flowing feather. Will make a magnificent horse.
Location: Cheshire

Global lithium sector eyes Argentina's salt flats on tech test run

Miningweekly.com 

In a dusty plain in northern Argentina's mountains, black tubes stretching two stories high fill a massive tank with salty brine sucked from deep below ground. The brine contains lithium, a silvery white metal essential for making electric vehicle batteries and in high demand as the world shifts to green energy. French miner Eramet is attempting to use an innovative technique, known as direct lithium extraction, or DLE, in a race for cleaner, faster and cheaper ways to produce the metal with less water.

Sea Dogs to Become the Lobster Bakes on August 23rd

OurSports Central 

Portland, Maine - The Portland Sea Dogs will become the Maine Lobster Bakes, presented by Maine Quit Link, for the Friday, August 23rd game when the t... - EL Portland Sea Dogs

Goldeyes Rally to Defeat Kansas City

OurSports Central 

WINNIPEG, MB - Held hitless for the first five innings, the Winnipeg Goldeyes (27-26) erupted for six runs in the sixth and went on to defeat the Kans... - AA Winnipeg Goldeyes

Zydus Life rises on USFDA nod for heart failure drug

Business Standard 

Zydus Lifesciences gained 1.81% to Rs 1187.15 after the company announced that it has received a final approval from the United States Food and Drug Administration (USFDA) to market Sacubitril and Valsartan tablets.